ADGRA2 Antibody Blocking Peptide(bs-21890P)-500ug

ADGRA2 Antibody Blocking Pepti

de(bs-21890P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-21890P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-21890P
    英文名称ADGRA2 Antibody Blocking Peptide
    中文名称G蛋白偶联受体124封闭多肽(肿瘤血管内皮标记物)
    纯化方法HPLC
    亚基Interacts with DLG1.
    亚细胞定位Cell membrane; Multi-pass membrane protein.
    组织特异性Expressed in endothelial cells (at protein level). Abundantly expressed in tumor vessels, heart, placenta, ovary, small intestine, and colon.
    相似性Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily.
    Contains 1 GPS domain.
    Contains 1 Ig-like (immunoglobulin-like) domain.
    Contains 4 LRR (leucine-rich) repeats.
    Contains 1 LRRCT domain.
    Contains 1 LRRNT domain.
    功能Endothelial receptor that acts as an essential regulator of CNS angiogenesis. Required for normal endothelial cell sprouting and migration in the forebrain and neural tube.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料Tumor endothelial markers (TEMs) are abundantly expressed in the blood vessels of human solid tumors during angiogenesis and neoangiogensis. These include TEM1 (endosialin), TEM5 (G-protein coupled receptor 124) and TEM7 (plexin domain containing 1). TEMs are associated with the cell surface membrane at low levels in normal human and mouse tissues. TEM5 is a seven-pass transmembrane receptor, whereas TEM1, TEM7 and TEM8 span the membrane once. TEM5 expression is elevated during tumor angiogenesis and neoangiogenesis. TEM7 is highly expressed in tumor endothelium and neurons. Therefore, TEM5 and TEM7 may be suitable targets for the development of antiangiogenic therapies.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1680
    武汉博欧特生物科技有限公司
    2025年03月03日询价
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    询价
    维百奥(北京)生物科技有限公司
    2025年11月18日询价
    询价
    缔码生物科技(武汉)有限公司
    2025年07月10日询价
    ¥4513.50
    深圳欣博盛生物科技有限公司
    2025年07月12日询价
    ADGRA2 Antibody Blocking Peptide(bs-21890P)-500ug
    ¥880